- Page 1 and 2:
MEDICAL DEVICE DAILY MDD’S BOOK
- Page 3 and 4:
About Medical Device Daily Medical
- Page 5 and 6:
TABLE OF CONTENTS
- Page 7 and 8:
PREFACE 33 ONE-ON-ONES THAT MATTER
- Page 9 and 10:
Preface reimbursement matters and s
- Page 11 and 12:
INTRODUCTION A LOOK AT SOME OF THE
- Page 13 and 14:
Introduction venture capitalists wh
- Page 15 and 16:
PHYLLIS GREENBERGER ADVOCATE FOR WO
- Page 17 and 18:
Phyllis Greenberger time that women
- Page 19 and 20:
Phyllis Greenberger their list of p
- Page 21 and 22:
ROBERT JARVIK HEART PUMP PIONEER
- Page 23 and 24:
Robert Jarvik As for when Jarvik He
- Page 25 and 26:
Robert Jarvik at the Texas Heart In
- Page 27 and 28:
ROBIN BELLAS VENTURE CAPITALIST
- Page 29 and 30:
Robin Bellas product side, for exam
- Page 31 and 32:
Robin Bellas used to be CEOs of our
- Page 33 and 34:
CHARLES KOLB PILOT OF PUBLIC POLICY
- Page 35 and 36:
Charles Kolb Marshall Plan. Through
- Page 37 and 38:
Charles Kolb political manner. The
- Page 39 and 40:
JOSEPH DEVIVO ADVOCATE OF ‘PERSON
- Page 41 and 42:
Joseph DeVivo agree with you that t
- Page 43 and 44:
Joseph DeVivo effort really picks u
- Page 45 and 46:
CHARLES MARONEY EXPERIENCED HAND AT
- Page 47 and 48:
Charles Maroney CD&D: You also ment
- Page 49 and 50:
Charles Maroney direction. So you s
- Page 51 and 52:
Charles Maroney cardiac surgery spa
- Page 53 and 54:
MIKE MUSSALLEM CEO AND INDUSTRY LEA
- Page 55 and 56:
Mike Mussallem All of those have be
- Page 57 and 58:
Mike Mussallem demands of a more ed
- Page 59 and 60:
GARY BURBACH FOCUSED ON QUALITY OF
- Page 61 and 62:
Gary Burbach It’s a big step forw
- Page 63 and 64:
NEWT GINGRICH FORMER U.S. REPRESENT
- Page 65 and 66:
Newt Gingrich BB&T: “Paper kills
- Page 67 and 68:
DON GERHARDT INDUSTRY ASSOCIATION C
- Page 69 and 70:
Don Gerhardt in different ways. It
- Page 71 and 72:
Don Gerhardt BB&T: How does the Lif
- Page 73 and 74:
CAROLYN CLANCY RESEARCH AND QUALITY
- Page 75 and 76:
Carolyn Clancy So I saw lots of var
- Page 77 and 78:
Carolyn Clancy But in healthcare we
- Page 79 and 80:
JOHN WILKINSON CHIEF EXECUTIVE, EUC
- Page 81 and 82:
John Wilkinson associations, and it
- Page 83 and 84:
John Wilkinson BB&T: Single-use dev
- Page 85 and 86:
ALEXANDER LEBER PIONEER IN CT, MRI
- Page 87 and 88:
Alexander Leber We also have an ent
- Page 89 and 90:
WINIFRED HAYES TECHNOLOGY ASSESSMEN
- Page 91 and 92:
Winifred Hayes BB&T: Your backgroun
- Page 93 and 94:
Winifred Hayes Hayes: I think it’
- Page 95 and 96:
STEFAN VILSMEIER WORLD-CLASS ENTREP
- Page 97 and 98:
Stefan Vilsmeier are often working
- Page 99 and 100:
Stefan Vilsmeier data, genetic data
- Page 101 and 102:
Stefan Vilsmeier from Day One. Othe
- Page 103 and 104:
TIM ULATOWSKI COMPLIANCE-FOCUSED RE
- Page 105 and 106:
Tim Ulatowski Ulatowski: The thresh
- Page 107 and 108:
Tim Ulatowski economic information
- Page 109 and 110: PAM MCNAMARA U.S. CEO, CAMBRIDGE CO
- Page 111 and 112: Pam McNamara BB&T: The whole area o
- Page 113 and 114: Pam McNamara another out of Peoria,
- Page 115 and 116: CHARLES CRAIG TRADE ASSOCIATION PRE
- Page 117 and 118: Charles Craig Let me offer a couple
- Page 119 and 120: Charles Craig derived from embryoni
- Page 121 and 122: Charles Craig The other key element
- Page 123 and 124: HANS HOFSTRAAT VICE PRESIDENT, PHIL
- Page 125 and 126: Hans Hofstraat BB&T: When Siemens r
- Page 127 and 128: Hans Hofstraat There is great promi
- Page 129 and 130: JACQUES SOUQUET FOUNDER AND CEO, SU
- Page 131 and 132: Jacques Souquet Souquet: Elasticity
- Page 133 and 134: DONNA-BEA TILLMAN DIRECTOR, OFFICE
- Page 135 and 136: Donna-Bea Tillman or one of those t
- Page 137 and 138: Donna-Bea Tillman Tillman: There we
- Page 139 and 140: Donna-Bea Tillman Just to make sure
- Page 141 and 142: HARRY GLORIKIAN CONSULTING FIRM FOU
- Page 143 and 144: Harry Glorikian think we’re going
- Page 145 and 146: Harry Glorikian with the customers
- Page 147 and 148: Harry Glorikian of looking at the s
- Page 149 and 150: GENE QUINN PATENT ATTORNEY AND FOUN
- Page 151 and 152: Gene Quinn Quinn: “It takes two t
- Page 153 and 154: Gene Quinn BB&T: The Supreme Court
- Page 155 and 156: LARRY HAIMOVITCH PRESIDENT OF HAIMO
- Page 157 and 158: Larry Haimovitch and there’s obvi
- Page 159: Larry Haimovitch approval likely in
- Page 163 and 164: Thomas J. Sommer year range. The IP
- Page 165 and 166: Thomas J. Sommer BB&T: Massachusett
- Page 167 and 168: BILL COOK FOUNDER OF DIVERSE MEDICA
- Page 169 and 170: Bill Cook handled by a medical regi
- Page 171 and 172: Bill Cook BB&T: You also cited the
- Page 173 and 174: JOHN S. TAYLOR VP OF RESEARCH FOR N
- Page 175 and 176: John S. Taylor We’re hoping for s
- Page 177 and 178: John S. Taylor know,” they actual
- Page 179 and 180: John S. Taylor BB&T: Beyond 2010, w
- Page 181 and 182: PAUL BROOKS VICE PRESIDENT OF BSI H
- Page 183 and 184: Paul Brooks program is really about
- Page 185 and 186: Paul Brooks Brooks: Exactly. We can
- Page 187 and 188: Paul Brooks so I think the European
- Page 189 and 190: JOSH MAKOWER MEDICAL INNOVATOR AND
- Page 191 and 192: Josh Makower medical investments an
- Page 193 and 194: Josh Makower We’re continuously t
- Page 195 and 196: Josh Makower takeaway from our disc
- Page 197 and 198: MARK DUVAL HIS LAW FIRM FOCUSES ON
- Page 199 and 200: Mark DuVal as industry does. That d
- Page 201 and 202: Mark DuVal also frequently asking t
- Page 203 and 204: Mark DuVal DuVal: When you compare
- Page 205 and 206: JUDY ROSENBLOOM HER FIRM FOCUSES ON
- Page 207 and 208: Judy Rosenbloom BB&T: That’s a go
- Page 209 and 210: Judy Rosenbloom out into the market
- Page 211 and 212:
Judy Rosenbloom the U.S., but the s
- Page 213 and 214:
SALLY C. PIPES ‘THINK-TANK’ HEA
- Page 215 and 216:
Sally C. Pipes BB&T: The old garbag
- Page 217 and 218:
Sally C. Pipes is part of the healt
- Page 219 and 220:
DAVID JOHNSON LEADS BIOCROSSROADS,
- Page 221 and 222:
David Johnson or anything else. Ind
- Page 223 and 224:
David Johnson We have had tremendou
- Page 225 and 226:
David Johnson electronic medical in